"
Membrane Proteins as Potential Colon Cancer Biomarkers: Verification of 4 Candidates from a Secretome Dataset"
written by Sum-Fu Chiang, Ming-Hung Tsai, Reiping Tang, Ling-Ling Hsieh, Jy-Ming Chiang, Chien-Yuh Yeh, Pao-Shiu Hsieh, Wen-Sy Tsai, Ya-Ping Liu, Ying Liang, Jinn-Shiun Chen, Jau-Song Yu,
published by
Surgical Science,
Vol.5 No.10, 2014
has been cited by the following article(s):
|
[1]
|
Risk scoring based on DNA methylation-driven related DEGs for colorectal cancer prognosis with systematic insights
Life Sciences,
2023
DOI:10.1016/j.lfs.2023.121413
|
|
|
|
|
[2]
|
Extracellular Vesicle Membrane Protein Profiling and Targeted Mass Spectrometry Unveil CD59 and Tetraspanin 9 as Novel Plasma Biomarkers for Detection of Colorectal Cancer
Cancers,
2022
DOI:10.3390/cancers15010177
|
|
|
|
|
[3]
|
Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study
Disease Markers,
2015
DOI:10.1155/2015/874054
|
|
|
|
|
[4]
|
Recursive Random Lasso (RRLasso) for Identifying Anti-Cancer Drug Targets
PLOS ONE,
2015
DOI:10.1371/journal.pone.0141869
|
|
|
|